Tuesday, August 14, 2018

Tuesday, August 14, 2018

 CGHS – REVISION OF CEILING RATES FOR REIMBURSEMENT OF THE COST OF CARDIAC PACEMAKER, AICD, COMBO-DEVICE, ROTABLATOR & AORTIC STENT GRAFT

Government of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare
Directorate Genera! of CGHS
Office of the Director, CGHS

NoS-11011/29/2018-CGHS(HEC)/ DIR/CGHS
Nirman Bhawan, New Delhi
Dated the 6th August, 2018
OFFICE MEMORANDUM

Subject:- Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules

With reference to the above subject attention is drawn to the OM No 12034/02/2014/Misc./­CGHS D.III dated 22nd July 2014 vide which ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS (MA) Rules were prescribed and to state that the matter has been reviewed by the Ministry and it is decided to revise the ceiling rates as per the details given under:

SI. NO.
CARDIAC DEVICE
CEILING RATE
1
Single Chamber Cardiac Pacemaker without Rate Response
Rs. 34,840/- + GST
2
Single Chamber Cardiac Pacemaker with Rate Response
Rs. 44.928/-+ GST
3
Dual Chamber Cardiac Pacemaker
Rs.83,200/-+ GST
4
Bi-Ventricular Cardiac Pacemaker
Rs.1,95,000/-+ GST
5
Implantable         Cardioverter         Defibrillator    (Single                      Chamber)(ICD/AICD-Single Chamber)
Rs.1,75.786/-+ GST
6
Implantable         Cardioverter         Defibrillator     (Dual                            Chamber)(ICD/AICD-Single Chamber)
Rs. 3,75,000/-+ GST
7
Combo Device (CRT-D)
Rs. 4,90,000/-+ GST
8
Aortic     Stent     Graft     (expandable,       bifurcated and including delivery system)
Rs. 4,40,960/- + GST
9
Rotablator with Advancer
Rs.49,920/-+ GST
10
Rotablator Burr
Rs.23,920/-+ GST

  1. Other terms and conditions prescribed under OM No 12034/02/2014/Misc./-CGHS D.III dated 22nd July 2014 shall remain unchanged.
  2. These rates shall remain valid till the rates for the above devices are notified by National Pharmaceutical Pricing Authority (NPPA).
  3. issued with the concurrence of SS&FA, Ministry of Health & Family Welfare vide CD — 1295 dated 25.07.2018.
Dr. Atul Prakash)
Director, CGHS

No comments:

Post a Comment